Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 194, Issue 11, Pages 1392-1402
Publisher
American Thoracic Society
Online
2016-06-17
DOI
10.1164/rccm.201509-1865oc
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis
- (2015) Yasmina Bauer et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
- (2014) Ganesh Raghu et al. Lancet Respiratory Medicine
- Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertensionin vivo
- (2013) Jonathan A. Fallowfield et al. HEPATOLOGY
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
- (2013) J. D. Herazo-Maya et al. Science Translational Medicine
- Cytokine-Like Factor 1 Gene Expression Is Enriched in Idiopathic Pulmonary Fibrosis and Drives the Accumulation of CD4+ T Cells in Murine Lungs
- (2012) Daniel J. Kass et al. AMERICAN JOURNAL OF PATHOLOGY
- The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe
- (2012) M. Nouraie et al. HAEMATOLOGICA
- Pulmonary fibrosis: patterns and perpetrators
- (2012) Paul W. Noble et al. JOURNAL OF CLINICAL INVESTIGATION
- Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
- (2012) John R Teerlink et al. LANCET
- Relaxin Regulates Myofibroblast Contractility and Protects against Lung Fibrosis
- (2011) Xiangwei Huang et al. AMERICAN JOURNAL OF PATHOLOGY
- Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Alveolar Epithelial Cells Undergo Epithelial-to-Mesenchymal Transition in Response to Endoplasmic Reticulum Stress
- (2011) Harikrishna Tanjore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The rising incidence of idiopathic pulmonary fibrosis in the UK
- (2011) V. Navaratnam et al. THORAX
- Lung Transplantation in the United States, 1999-2008
- (2010) R. D. Yusen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension
- (2010) Eileen Hsu et al. ARTHRITIS AND RHEUMATISM
- Prevention of Bleomycin-Induced Pulmonary Fibrosis by a Novel Antifibrotic Peptide with Relaxin-Like Activity
- (2010) A. Pini et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double-blind, placebo-controlled trial
- (2009) Dinesh Khanna et al. ARTHRITIS AND RHEUMATISM
- Relaxin and its role in the development and treatment of fibrosis
- (2009) Robert G. Bennett Translational Research
- Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
- (2008) Ishanee Mookerjee et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search